Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis-Reference-Cited by-同舟云学术

Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis

Published:2014-03-15 Issue:6 Volume:71 Page:463-469
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Hanson Rebekah L.¹,Habibi Mitra²,Khamo Nehrin³,Abdou Sherif⁴,Stubbings JoAnn³

Affiliation:

1. Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago (UIC), Chicago

2. Department of Neurology, University of Illinois Hospital and Health Sciences System, Chicago, and Clinical Assistant Professor, College of Pharmacy, UIC

3. Department of Pharmacy Practice, College of Pharmacy, UIC

4. Specialty Pharmacy Services, Department of Pharmacy Practice, College of Pharmacy, UIC

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/71/6/463/28372325/ajhp0463.pdf

Reference21 articles.

1. National Multiple Sclerosis Society. What we know about MS: what is MS?www.nationalmssociety.org/about-multiple-sclerosis/what-we-know-about-ms/what-is-ms/index.aspx (accessed 2013 Jul 17).

2. National Multiple Sclerosis Society. What we know about MS: treatments. www.nationalmssociety.org/about-multiple-sclerosis/what-we-know-about-ms/treatments/index.aspx (accessed 2013 Jul 17).

3. National Clinical Advisory Board of the National Multiple Sclerosis Society. Expert opinion paper. Treatment recommendations for physicians. http://main.nationalmssociety.org/docs/HOM/Exp_ChangTherapy.pdf (accessed 2013 Dec 9).

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Pharmaceutical recommendations for therapeutic appropriateness in patients with multiple sclerosis;Farmacia Hospitalaria;2024-09

2. Recomendaciones farmacéuticas de adecuación terapéutica en pacientes con esclerosis múltiple;Farmacia Hospitalaria;2024-09

3. Describing and Evaluating the Clinical Pharmacist’s Role in a Canadian Multiple Sclerosis Clinic;Canadian Journal of Hospital Pharmacy;2024-07-10

4. Consensus quality indicators for monitoring multiple sclerosis;The Lancet Regional Health - Europe;2024-05

5. Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosis;Journal of Managed Care & Specialty Pharmacy;2024-04